Bevacizumab or laser for aggressive posterior retinopathy of prematurity

PURPOSE: The purpose of this study was to report the rate of reactivation and structural outcome, after the laser or bevacizumab treatment for aggressive posterior retinopathy of prematurity (APROP). METHODS: Retrospective chart review was conducted on consecutive infants with APROP treated with (1)...

Descripción completa

Detalles Bibliográficos
Autores principales: Blair, Michael, Gonzalez, Jose Maria Garcia, Snyder, Laura, Schechet, Sidney, Greenwald, Mark, Shapiro, Michael, Rodriguez, Sarah Hilkert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302568/
https://www.ncbi.nlm.nih.gov/pubmed/30637196
http://dx.doi.org/10.4103/tjo.tjo_69_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302568/
https://www.ncbi.nlm.nih.gov/pubmed/30637196
http://dx.doi.org/10.4103/tjo.tjo_69_18

Ejemplares similares